The government of Israel has admitted in court that it has failed to locate its COVID-19 vaccine agreement with Pfizer despite an extensive search. In 2020, Israel secured vaccines from Pfizer on a priority basis, promising to provide epidemiological data of its citizens in exchange. In a petition pending at the Jerusalem District Court, the…

Recently both Pfizer and Moderna announced they were developing a combination injection utilizing mRNA coding for the BA4/BA5 Omicron subvariant and new mRNA coding for antigens contained in the influenza virus.[i]  Because the COVID-19 component is under Emergency Use Authorization, has failed animal data and no human studies, that component should be off the table…

Pfizer is looking to raise the price of its COVID-19 vaccines in the United States by up to four times once Washington’s purchase program ends, according to the company’s U.S. president, Angela Lukin. Pfizer’s COVID-19 vaccine is presently provided free for all Americans by the U.S. government. Next year, when the U.S. public health emergency…

Vaccinations in pregnancy have always been a key topic in the medical sector. A research team composed of National Mie Hospital in Japan discovered recently that after a pregnant woman is COVID-19 vaccinated, antibodies from the mother can be transferred to the fetus, which helps to protect the mother and newborn at the same time….

Health Canada approved on Sept. 9 the use of Pfizer’s COVID-19 vaccine in children aged 6 months to less than 5 years old, making it the second vaccine approved for the youngest cohorts of children in Canada. The federal agency said on its website that the dosage it has approved for children in this age…

Pfizer and partner BioNTech announced they have submitted a request to the U.S. Food and Drug Administration (FDA) to authorize a COVID-19 vaccine booster that has been updated to target the newest Omicron subvariants. The request comes after the FDA in June advised COVID-19 vaccine makers to amend their shots to target the two Omicron subvariants BA.4…

Siu Yick-tung, an 11-year-old girl from Hong Kong, was admitted to hospital with chest pains three weeks after receiving the second dose of COVID-19 vaccination. She was later diagnosed with myocarditis. Siu’s condition deteriorated sharply at the time, and she had to be admitted to the intensive care unit (ICU). Siu’s aunt posted updates on…

Recently, an 11-year-old Hong Kong girl was vaccinated with Pfizer-BioNTech (復必泰) vaccine and had symptoms of myocarditis, and her life was in danger. The public was greatly concerned by this incident. Since then the Hong Kong Centre for Health Protection extended the interval between the first and second doses of Pfizer-BioNTech vaccine from three to eight…

An 11-year-old Hong Kong girl vaccinated with the Pfizer-BioNTech vaccine had symptoms of myocarditis. Since then, the Hong Kong Centre for Health Protection extended the interval between the first and second doses of the Pfizer-BioNTech vaccine from three to eight weeks for people between 18 and 59. Dr. Edmund Lam Wing-wo, a member of the Scientific Committee…

An 11-year-old Hong Kong girl vaccinated with the Pfizer-BioNTech vaccine had symptoms of myocarditis. Since then, the Hong Kong Centre for Health Protection extended the interval between the first and second doses of the Pfizer-BioNTech vaccine from three to eight weeks for people between 18 and 59. Dr. Edmund Lam Wing-wo, a member of the Scientific Committee…